What is the appropriate management for a 70-year-old woman presenting with supraventricular tachycardia?

Management of SVT in a 70-Year-Old Woman

For a 70-year-old woman presenting with SVT, begin immediately with vagal maneuvers (Valsalva or carotid massage) if she is hemodynamically stable, followed by IV adenosine 6 mg rapid push if vagal maneuvers fail—this approach terminates 90-95% of SVT cases. 1

Acute Management Algorithm

Step 1: Assess Hemodynamic Stability

• Unstable (hypotension, altered mental status, chest pain, acute heart failure): Proceed directly to synchronized cardioversion 1
• Stable: Continue with stepwise approach below

Step 2: First-Line Therapy for Stable Patients

Vagal Maneuvers (perform immediately):

• Valsalva maneuver: Patient bears down against closed glottis for 10-30 seconds (30-40 mmHg pressure) in supine position 1, 2
• Carotid sinus massage: Apply steady pressure for 5-10 seconds after confirming no bruit 1, 2
• Ice-cold towel to face: Alternative diving reflex maneuver 1
• Success rate: 27.7% when switching between techniques 1

Critical caveat: Never apply pressure to eyeballs—this is dangerous and abandoned 1

Step 3: Pharmacologic Therapy

Adenosine (first-line medication):

• Dose: 6 mg rapid IV push via proximal vein, followed immediately by saline flush 1
• If unsuccessful: Give 12 mg rapid push
• Success rate: 90-95% for AVNRT/AVRT 1
• Side effects: Brief (<1 min) chest discomfort, flushing, shortness of breath—but serious adverse effects are rare 1
• Essential: Have continuous ECG recording during administration and keep cardioversion equipment immediately available (adenosine can precipitate AF with rapid ventricular response) 1

Step 4: Second-Line Medications (if adenosine fails or contraindicated)

IV Calcium Channel Blockers (preferred in elderly):

• Diltiazem or verapamil: 64-98% conversion success 1
• Administration: Slow infusion up to 20 minutes reduces hypotension risk 1
• Contraindications: Avoid in systolic heart failure, pre-excited AF, or VT 1

IV Beta-Blockers:

• Reasonable alternative with excellent safety profile 1
• Less effective than diltiazem for SVT termination 1

Step 5: Cardioversion

If all pharmacologic therapy fails or is contraindicated, perform synchronized cardioversion under sedation 1

Special Considerations for Elderly Patients (Age 70+)

Important age-related factors:

• Higher rates of underlying structural heart disease and ischemic heart disease 3
• More likely to have AVNRT (rather than AVRT) 3
• Higher risk of misdiagnosis: 15% of elderly SVT patients were incorrectly diagnosed with atrial tachycardia or VT before proper evaluation 4
• Increased procedural complications with ablation (though acute success rates remain high) 3, 4

Critical pitfall: In elderly patients with wide QRS tachycardia, don't assume VT—14% of elderly SVT patients were misdiagnosed as VT due to aberrant conduction 4

Ongoing Management Considerations

For recurrent symptomatic episodes:

• Catheter ablation should be strongly considered as definitive therapy, even in elderly patients 3, 5
• Success rates remain high in patients ≥70 years despite slightly increased complication risk 3
• A 96-year-old successfully underwent ablation, highlighting that age alone should not preclude this option 5

Chronic suppressive therapy (if ablation declined):

• Oral verapamil or diltiazem: Well-tolerated, effective alternatives 1
• Avoid in systolic heart failure 1

Monitor for: Higher long-term risks of AF development, stroke, and need for pacemaker in elderly SVT patients 4